Q4 EPS Estimates for Henry Schein Cut by Barrington Research

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Barrington Research decreased their Q4 2024 earnings estimates for Henry Schein in a research report issued to clients and investors on Wednesday, November 6th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings of $1.20 per share for the quarter, down from their previous estimate of $1.27. Barrington Research has a “Outperform” rating and a $82.00 price objective on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s Q1 2025 earnings at $1.12 EPS, Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.27 EPS, Q4 2025 earnings at $1.46 EPS, FY2025 earnings at $5.12 EPS and FY2026 earnings at $5.80 EPS.

Other equities analysts have also recently issued research reports about the stock. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Robert W. Baird cut their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. JPMorgan Chase & Co. decreased their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday. Finally, Evercore ISI upped their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Henry Schein has a consensus rating of “Hold” and an average target price of $77.50.

Henry Schein Trading Down 0.8 %

Henry Schein stock opened at $69.43 on Thursday. Henry Schein has a one year low of $62.12 and a one year high of $82.63. The business’s fifty day moving average is $70.56 and its 200 day moving average is $69.78. The stock has a market capitalization of $8.80 billion, a PE ratio of 25.71, a price-to-earnings-growth ratio of 2.08 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.32 EPS.

Insider Activity at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.14% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Pathstone Holdings LLC increased its stake in Henry Schein by 3.1% in the 3rd quarter. Pathstone Holdings LLC now owns 24,028 shares of the company’s stock worth $1,752,000 after buying an additional 732 shares in the last quarter. Banyan Capital Management Inc. boosted its stake in shares of Henry Schein by 1.9% in the third quarter. Banyan Capital Management Inc. now owns 127,434 shares of the company’s stock worth $9,290,000 after acquiring an additional 2,351 shares during the period. Clarkston Capital Partners LLC grew its position in shares of Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after purchasing an additional 71,560 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in Henry Schein by 1,848.9% during the 3rd quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company’s stock valued at $7,685,000 after purchasing an additional 100,006 shares during the period. Finally, Natixis Advisors LLC lifted its holdings in Henry Schein by 18.8% in the 3rd quarter. Natixis Advisors LLC now owns 81,877 shares of the company’s stock worth $5,969,000 after purchasing an additional 12,930 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.